Pharmacokinetic Drug Interactions Between HGP1607 and HGP1501

Phase 1 Completed 30 enrolled Hanmi Pharmaceutical Company Limited

RandomizedCrossoverOpen-labelTreatment

Summary

A Randomized, Open-label, Crossover Study to Investigate the Pharmacokinetic drug interactions and the Safety between HGP1607 and HGP1501 in Healthy Male Volunteers

Timeline

Start: 2017-03-31
Primary completion: 2017-05-28
Completion: 2017-06-16

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	HGP1501	Unknown	—	—
Subject	HGP1607	Unknown	—	—

Indications

No indication recorded.